Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS
Contenu archivé le 2024-05-27

Suppression of Enzymes Required for Progression of LUng Cancer

Objectif

"Suppression of enzymes required for progression of lung cancer: we propose to combine an elegant genetically engineered mouse model (GEMM) of lung cancer with an in vivo RNAi screening approach in order to functionally identify a) biomarkers of early lung cancer development and b) candidate therapeutic targets whose activities are specifically required for the transition from benign to malignant disease. We will use emerging RNA sequencing technology to identify changes in gene expression associate with early cancer progression in GEMMs of lung cancer and then select targets for RNAi suppression based on a stringent set of selection criteria aimed at zeroing in on potential drug targets, i.e.. proteins with enzymatic activity of any druggable nature that increase with tumour progression. We will then generate focused libraries of shRNAs to suppress expression of selected targets and screen their efficacy in vivo using a cunning ""drop-out"" screening method. We will then subject our best candidates to rigorous validation in order to assess their suitability as therapuetic targets in the context of human lung cancer."

Champ scientifique (EuroSciVoc)

Programme(s)

Thème(s)

Appel à propositions

FP7-PEOPLE-2013-CIG
Voir d’autres projets de cet appel

Régime de financement

MC-CIG - Support for training and career development of researcher (CIG)

Coordinateur

UNIVERSITY OF GLASGOW
Contribution de l’UE
€ 100 000,00
Adresse
UNIVERSITY AVENUE
G12 8QQ Glasgow
Royaume-Uni
Région
Scotland West Central Scotland Glasgow City
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée